"The
Report Iron Deficiency Anemia - Pipeline Review, H2 2016 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
Global
Markets Directs, Iron
Deficiency Anemia
- Pipeline Review, H2 2016, provides an overview of the Iron
Deficiency Anemia pipeline landscape.
The
report provides comprehensive information on the therapeutics under
development for Iron Deficiency Anemia, complete with analysis by
stage of development, drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in therapeutic development for Iron Deficiency Anemia and features
dormant and discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Get
the Free Sample copy of this Report @
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Iron Deficiency Anemia
-
The report reviews pipeline therapeutics for Iron Deficiency Anemia
by companies and universities/research institutes based on
information derived from company and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved Iron Deficiency Anemia
therapeutics and enlists all their major and minor projects
-
The report assesses Iron Deficiency Anemia therapeutics based on drug
target, mechanism of action (MoA), route of administration (RoA) and
molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Iron Deficiency Anemia
Reasons to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Iron Deficiency Anemia
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Iron Deficiency Anemia pipeline depth and focus of Indication
therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table
of Contents
Table
of Contents 2
List
of Tables 5
List
of Figures 5
Introduction
6
Global
Markets Direct Report Coverage 6
Iron
Deficiency Anemia Overview 7
Therapeutics
Development 8
Pipeline
Products for Iron Deficiency Anemia - Overview 8
Pipeline
Products for Iron Deficiency Anemia - Comparative Analysis 9
Iron
Deficiency Anemia - Therapeutics under Development by Companies 10
Iron
Deficiency Anemia - Therapeutics under Investigation by
Universities/Institutes 11
Iron
Deficiency Anemia - Pipeline Products Glance 12
Late
Stage Products 12
Clinical
Stage Products 13
Early
Stage Products 14
Iron
Deficiency Anemia - Products under Development by Companies 15
Iron
Deficiency Anemia - Products under Investigation by
Universities/Institutes 16
Iron
Deficiency Anemia - Companies Involved in Therapeutics Development 17
Galenica
Ltd. 17
Johnson
& Johnson 18
Novartis
AG 19
Panion
& Bf Biotech Inc 20
Pieris
Pharmaceuticals, Inc. 21
Rockwell
Medical, Inc. 22
Iron
Deficiency Anemia - Therapeutics Assessment 23
Assessment
by Monotherapy Products 23
Assessment
by Target 24
Assessment
by Mechanism of Action 26
Assessment
by Route of Administration 28
Assessment
by Molecule Type 30
Drug
Profiles 32
CSJ-137
- Drug Profile 32
Product
Description 32
Mechanism
Of Action 32
R&D
Progress 32
Drug
to Repalce Iron for Iron Deficiency Anemia - Drug Profile 33
Product
Description 33
Mechanism
Of Action 33
R&D
Progress 33
ferric
carboxymaltose - Drug Profile 34
Product
Description 34
Mechanism
Of Action 34
R&D
Progress 34
ferric
citrate - Drug Profile 36
Product
Description 36
Mechanism
Of Action 36
R&D
Progress 36
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA:
Canada Toll Free: 866-997-4948
No comments:
Post a Comment